Not for distribution in the U.S. or to U.S. Newswires

VANCOUVER, British Columbia, Aug. 22, 2018 (GLOBE NEWSWIRE) -- BlissCo Cannabis Corp.  (CSE: BLIS) (FRA: GQ4B), (“BlissCo”) or the (“Company”) is pleased to announce that the company is on track with its milestones and laying a strong foundation for sustainable domestic and international revenue growth.

“With two supply partnerships under our belt, an oil production license secured and a telemedicine smartphone app set to launch, we are well on our way to hit the ground running come legalization,” said Damian Kettlewell, CEO of BlissCo Cannabis Corp. 

The company is also on track to receive its sales license in 2018, launch a Shopify e-commerce website and unveil the next evolution of its brand for its projected October launch. “A focus on our patients is paramount to us, so we have put a lot of care into selecting our partners and distribution channels. The momentum is building daily and we are consistently meeting our milestones and building sustainable partnerships that will allow us to execute on our growth and revenue strategies,” added Kettlewell.

About BlissCo Cannabis Corp. BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B) is an ACMPR licensed producer and future distributor of ultra-premium cannabis. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships. 

BlissCo leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.

BlissCo is backed by an experienced team that is deeply in tune and integrated with industry partners and BlissCo's future patients and customers.

Learn more:  BlissCo.com

On Behalf of the Board of Directors

BLISSCO CANNABIS CORP.

Damian Kettlewell, CEO, Founder & Chair

For further information please contact:

Ariel Jack Lewinski, Business Development & Investor Relations

#604 377 75343 ariel.lewinski@blissco.com  

Cautionary Statement

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.